The end of an era

As you may have seen in an earlier post, I’m moving on from Development after 13+ years as the journal’s Executive Editor. The good news (for me at least!) is that I’m not going far – I’m taking up a new position here at The Company of Biologists as the Publishing Director, overseeing our editorial programme and supporting the activities of all five of our journals. This means I’ll still be very involved with Development, though much more on the publishing side of things than the science – and this is definitely a real wrench for me. I love developmental biology, I love the community and I love working with such a fantastic and dedicated team of academic editors and in-house staff. But it was time for me to move on – after all this time, I’m ready for a new challenge. And I’m excited to announce that we’ve appointed Alex Eve, who’s been with the journal as a Reviews and then Senior Editor since late 2018, as the new Executive Editor. His knowledge of, enthusiasm for and dedication to the field mean that the journal’s going to be in great hands. You can expect to hear a bit more from Alex and his plans in the coming weeks.

As I turn my attention to my new role, I’ve also been thinking back over the past 13 years and thought I’d share some (perhaps a slightly random selection of!) particularly memorable activities and moments (big and small) from my time here at Development…

When I first joined the journal in late 2011, Olivier Pourquié had been in place as Editor-in-Chief for almost two years, and one of his major focusses was on attracting stem cell scientists to Development as a journal. Olivier, earlier than most, recognised the potential in the synergy between the established field of in vivo embryology and the burgeoning in vitro stem cell field, but also saw a divide between the two communities. I’ll admit that – at first – I was sceptical about the hype surrounding stem cell biology, but Olivier’s viewpoint was persuasive and he rapidly won me around. One of my early tasks was therefore to think about ways in which we could bring the stem cell and developmental biology communities closer together – to benefit both the journal and the fields more broadly. One major initiative in this area was the ‘From stem cells to human development’ meeting – which Olivier and I initially conceived in 2013, and which first ran in September 2014. I’ll be writing more extensively about these meetings for Development later in the year, but suffice to say that I’m super-proud of how this first meeting, and the biennial series it spawned, panned out in supporting and promoting the growing field of human developmental biology. The meeting is still going strong, and I’m delighted that – next year – the journal is partnering with the Wellcome-funded Human Developmental Biology Initiative (HDBI) to run the next edition of this conference.

Another highlight from my early years was visiting the Woods Hole Embryology course back in 2013. Nipam Patel, then the course director and an Editor at Development (and now Director of the Marine Biological Laboratory; MBL), invited me to the MBL to give a talk to the students and find out more about the course – which The Company of Biologists has been supporting for many years (look out for more on the relationship between the Company and the course in an upcoming issue of the journal). I was able to tag this visit on to an already-planned trip to Boston for the International Society for Stem Cell Research (ISSCR) Annual Meeting (incidentally leading to a hotel booking error that left me homeless for a night in Boston!), and visiting Woods Hole – albeit for just 24 hours – reinforced my regret at never having taken the course myself. As well as giving a talk, Nipam roped me in to helping the students with fly imaginal disc dissections – something I’d not done for around a decade at the time but somehow still retained the muscle memory for – and with some imaging experiments. While I’ve never regretted leaving lab science behind, it’s the dissections, injections, and transplantations that I missed – so having just a brief opportunity to do some of this again was a real pleasure for me! As well as the ISSCR meeting, that trip also took in the International Society for Developmental Biology (ISDB) conference in Cancun (and the added bonus of watching a turtle crawling up on to the beach at night to lay eggs) – making it a really memorable, if hectic, couple of weeks.

Another ISSCR meeting makes my list of conferences never to be forgotten, though for a very different reason. 23 June 2016 – I was in San Francisco while, back here in the UK, the country was voting in the Brexit referendum. As votes were being counted, I was at the President’s Reception at the ISSCR meeting, where I should have been chatting about the latest stem cell research, but was actually watching my phone, incredulous, as the ‘leave’ vote mounted – with a similarly shocked group of academics around me. I remember going to bed with the radio on, listening to David Cameron resign and thinking that I might just stay in the US (we were still in the Obama days back then…!). The UK is still feeling the negative ramifications of that vote, though I’d definitely rather be here than Stateside right now…

Back in the office, one of the contributions I feel I’ve personally made to the Company and its journals has been in pushing the preprint agenda. Again, Olivier was prescient on this front and James Briscoe – the journal’s current Editor-in-Chief – has also been very active in this area. When bioRxiv launched in late 2013, Olivier and I really felt this was a game-changer in the publishing ecosystem, so we rapidly changed journal policy to allow preprinting and initiated discussions with bioRxiv to facilitate co-submission to the journal and the preprint server. Since then, I’ve been very involved in various initiatives related to preprints – from the launch of preLights to cross-publisher discussions around preprint peer review – and it’s great to see how the uptake of preprint posting has grown in our community over the years. Moving forwards, this is something that I’ll continue to work on: the value in early sharing of manuscripts, both for the individual researcher and the broader research community, is undeniable and I see the preprint ecosystem as a benefit not a threat to journals.

Over the past couple of years, I’ve also really enjoyed setting up the Pathway to Independence programme. Kudos for this one goes to James – the idea of setting up a scheme to support postdocs going on the job market was all his, but I’m delighted to have played my part in putting this into action. We’ve just selected our third cohort of PI Fellows, and we’re looking forward to starting to work with them. It’s a privilege to help support the next generation of leaders of our field, and I do hope that – in a small way at least – we’ve helped some of them get their foot on the ladder. I hope that, going forwards, we can continue to grow a supportive network of PIs from across the breadth of our field.

From a scientific perspective, the past decade-and-a-bit has been hugely exciting too. It seems bizarre, but when I started at Development, we had no CRISPR-based genome editing, no single-cell RNAseq, and organoids were very much in their infancy (one of the earliest Review articles I comissioned and edited at the journal on was this piece from Yoshiki Sasai and colleagues; his early work on recapitulating optic cup development in vitro will forever be one of the most mindblowing papers I’ve read). To name just a few areas, we’ve also seen tremendous advances in 4D imaging of developmental processes, in our appreciation of the contribution of biophysical forces to development and in our understanding of how genomic elements interact to direct the complex and dynamic patterns of gene expression required to orchestrate development. But we’ve still got so much more to learn – and while I know that there has been a lot of angst in the developmental biology community regarding its place in the broader scientific enterprise and how the field is prioritised for funding, I maintain that (current political circumstances aside) there is no more exciting time to be a developmental biologist than now.

Finally, though, what I’m perhaps most proud of from my time at Development is the people I’ve worked with – both the academic editors, whose dedication to this role never fails to impress me, and the in-house team. When I first arrived at the Company – with zero management experience, limited knowledge of how publishing works and feeling very apprehensive about the new challenge – I was told by the then Company Secretary “you’ll be fine – Development’s got a great team”. They were right, and this continues to be true to this day. I’ve been lucky to work with a wonderful group of in-house staff, including four individuals who were part of my team when I joined and still work for the Company to this day, and several who’ve left and gone on to do fabulous things elsewhere. I hope that I’ve helped them succeed with their career aspirations, whatever they may have been, and I celebrate their ongoing successes. I’m super-lucky that two of them – Seema Grewal (now Executive Editor of Journal of Cell Science) and Alex Eve – are a part of my new team so I can continue to work with them in the months and years to come.

Right now, I’m still figuring out exactly what my new job involves – it’s a new position here at the Company – and for the time being, I’ll be focussing on learning about the other journals and their communities and really getting my head around what matters most to our authors, reviewers and readers. These are interesting times in academic publishing: there’s a fair bit of (understandable) discontent out there about how the whole process works which, combined with things like changing business models and the rise of AI-based technologies, means that there’s an awful lot for me to think about!

(No Ratings Yet)

Loading...